Dr. Clay Siegall is one of the most well-respected guys in cancer research. He has used his brilliance and ingenuity for saving the lives of people who suffer with cancer. Dr. Siegall is the CEO and president for one of the most successful biotechnology companies in the world. Seattle Genetics sit at the pinnacle of the industry, and it is leading by example. By implementing drug development, rigorous research and scientific innovation into the program, the company’s stock has skyrocketed over the past few years. To simply state it, the company’s stock has tripled in over a five year timeframe.
Anti-body Based Therapies are winning in the fight against cancer. These therapies are actually broken down into anti-body drug conjugates, and these drugs delivers a cell killing blow. They’re targeted medications, which means that they are designed to seek out and to destroy cancer cells in the human body. No other cancer drugs can compete with this and Seattle Genetics are the only company that produces it. The company is so successful, but not just by leadership alone. It is successful because it sticks to its core values of integrity, teamwork, passion and scientific excellence. Dr. Siegall founded the company back in the late 1990s, but who ever knew that it would grow into such a prestigious organization?
ADCETRIS, the company’s top drug, has raked in up to $350 million. On the other hand, Dr. Siegall has done a lot of fundraising, which has added up to $1.2 billion. This man and the company is very progressive in nature because time is of the essence. Since he began his career decades ago, Dr. Siegall has become a well-respected author with more than 70 publications under his belt. He also holds at least 15 patents.